These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7119136)

  • 21. Decay in plasma lithium and normalization in red blood cell choline following cessation of lithium treatment in two elderly individuals with Alzheimer-type dementia.
    Pomara N; Block R; Domino EF; Gershon S
    Biol Psychiatry; 1984 Jun; 19(6):919-22. PubMed ID: 6430359
    [No Abstract]   [Full Text] [Related]  

  • 22. Lecithin does not affect EEG spectral analysis or P300 in Alzheimer disease.
    Canter NL; Hallett M; Growdon JH
    Neurology; 1982 Nov; 32(11):1260-6. PubMed ID: 6890160
    [No Abstract]   [Full Text] [Related]  

  • 23. [Recent drug therapy of senile dementia].
    Ohtomo E
    No To Shinkei; 1987 Jan; 39(1):49-58. PubMed ID: 3030382
    [No Abstract]   [Full Text] [Related]  

  • 24. Elevation of RBC glycine and choline levels in geriatric patients treated with lithium.
    Pomara N; Banay-Schwartz M; Block R; Stanley M; Gershon S
    Am J Psychiatry; 1983 Jul; 140(7):911-3. PubMed ID: 6407342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-related physostigmine-induced ventricular arrhythmia: case report.
    Dysken MW; Janowsky DS
    J Clin Psychiatry; 1985 Oct; 46(10):446-7. PubMed ID: 4044537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choline chloride fails to improve cognition of Alzheimer's disease.
    Thal LJ; Rosen W; Sharpless NS; Crystal H
    Neurobiol Aging; 1981; 2(3):205-8. PubMed ID: 7312098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of various psychopharmacological combinations in the treatment of presenile and senile primary degenerative dementia.
    Tudorache B; Lupulescu R; Duţan I; Sârbulescu A
    Rom J Neurol Psychiatry; 1990; 28(4):277-94. PubMed ID: 2100154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early results from double-blind, placebo controlled trial of high dose phosphatidylcholine in Alzheimer's disease.
    Levy R; Little A; Chuaqui P; Reith M
    Lancet; 1983 Apr; 1(8331):987-8. PubMed ID: 6132292
    [No Abstract]   [Full Text] [Related]  

  • 29. Choline chloride in Alzheimer disease.
    Thal LJ; Rosen W; Sharpless NS; Crystal H
    Ann Neurol; 1981 Dec; 10(6):580. PubMed ID: 7325608
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preliminary results of a long-term double-blind study of naftidrofuryl and a placebo in patients with moderate Alzheimer-type senile dementia].
    Cucinotta D; Dall'Asta D; Benaglia F; Barbagallo M; Butturini L; Pioli G; Salomone M
    G Clin Med; 1985; 66(11-12):467-76. PubMed ID: 3835091
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug combination may improve memory.
    Geriatrics; 1979 Oct; 34(10):15. PubMed ID: 478303
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease.
    Smith RC; Vroulis G; Johnson R; Morgan R
    Psychopharmacol Bull; 1984; 20(3):542-5. PubMed ID: 6433396
    [No Abstract]   [Full Text] [Related]  

  • 33. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease.
    Xu SS; Gao ZX; Weng Z; Du ZM; Xu WA; Yang JS; Zhang ML; Tong ZH; Fang YS; Chai XS
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):391-5. PubMed ID: 8701750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modest facilitation on memory in dementia with combined lecithin and anticholinerestase treatment.
    Kaye WH; Sitaram N; Weingartner H; Ebert MH; Smallberg S; Gillin JC
    Biol Psychiatry; 1982 Feb; 17(2):275-80. PubMed ID: 7074185
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction of cholesterol risk factors by lecithin in patients with Alzheimer's disease.
    Vroulis G; Smith RC; Schoolar JC; Dahlen G; Katz E; Misra CH
    Am J Psychiatry; 1982 Dec; 139(12):1633-4. PubMed ID: 7149071
    [No Abstract]   [Full Text] [Related]  

  • 37. [Citalopram in treatment of behavioral disorders in demented patients].
    Leblhuber F
    Acta Med Austriaca; 1994; 21(4):104-6. PubMed ID: 7871964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of naloxone in senile dementia: a double-blind trial.
    Reisberg B; Ferris SH; Anand R; Mir P; Geibel V; De Leon MJ; Roberts E
    N Engl J Med; 1983 Mar; 308(12):721-2. PubMed ID: 6338389
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease.
    Asthana S; Greig NH; Holloway HW; Raffaele KC; Berardi A; Schapiro MB; Rapoport SI; Soncrant TT
    Clin Pharmacol Ther; 1996 Sep; 60(3):276-82. PubMed ID: 8841150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lecithin in the treatment of Alzheimer's disease.
    Weintraub S; Mesulam MM; Auty R; Baratz R; Cholakos BN; Kapust L; Ransil B; Tellers JG; Albert MS; LoCastro S; Moss M
    Arch Neurol; 1983 Aug; 40(8):527-8. PubMed ID: 6347143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.